IRIS PubliCatt

Lopetuso, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.150
EU - Europa 2.769
AS - Asia 1.168
SA - Sud America 22
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 2
Totale 7.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.092
SE - Svezia 704
IT - Italia 620
DE - Germania 531
CN - Cina 512
SG - Singapore 334
IE - Irlanda 202
FR - Francia 188
UA - Ucraina 124
ID - Indonesia 122
GB - Regno Unito 85
PL - Polonia 80
RU - Federazione Russa 71
IN - India 61
FI - Finlandia 58
TR - Turchia 44
CA - Canada 42
BE - Belgio 28
IR - Iran 23
BR - Brasile 16
HK - Hong Kong 15
JP - Giappone 15
KR - Corea 15
NL - Olanda 14
ES - Italia 13
MX - Messico 13
EU - Europa 10
CI - Costa d'Avorio 9
CZ - Repubblica Ceca 8
RO - Romania 6
GR - Grecia 5
LT - Lituania 5
VN - Vietnam 5
EG - Egitto 4
NO - Norvegia 4
TW - Taiwan 4
CL - Cile 3
EE - Estonia 3
HU - Ungheria 3
IL - Israele 3
PT - Portogallo 3
TH - Thailandia 3
ZA - Sudafrica 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
IQ - Iraq 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
PH - Filippine 2
RS - Serbia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GL - Groenlandia 1
LI - Liechtenstein 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TN - Tunisia 1
UG - Uganda 1
Totale 7.140
Salva come PNG Salva come JPEG
Città #
Chandler 817
Ashburn 275
Singapore 267
Dublin 197
Jakarta 121
Beijing 118
Cattolica 114
New York 110
Ann Arbor 93
San Mateo 90
Boston 88
Jacksonville 82
Wilmington 81
Princeton 73
Fairfield 71
Rome 70
Milan 69
Nanjing 68
Warsaw 62
Marseille 61
Woodbridge 52
Moscow 50
Dearborn 49
Houston 47
Seattle 46
Hangzhou 44
Redwood City 42
Izmir 39
Los Angeles 35
Lawrence 28
Boardman 26
Bremen 26
Brussels 25
Augusta 24
Shanghai 24
London 23
Munich 23
Helsinki 22
Lancaster 21
Nürnberg 21
Pune 21
Redmond 21
Guangzhou 20
Andover 19
Tianjin 19
Shenyang 18
Cambridge 17
Nanchang 17
Norwalk 17
Jiaxing 16
Kraków 16
Hebei 15
Mountain View 13
Zhengzhou 13
Chicago 12
Kunming 12
Toronto 12
Fremont 11
Kish 11
Changsha 10
Leawood 10
Washington 10
Abidjan 9
Jinan 9
Falls Church 8
Frankfurt am Main 8
Lappeenranta 7
Monza 7
Ottawa 7
Seoul 7
Tokyo 7
Trieste 7
Verona 7
Brno 6
Hong Kong 6
Paris 6
San Diego 6
San Francisco 6
Atlanta 5
Busto Arsizio 5
Esslingen am Neckar 5
Giessen 5
Millbury 5
Trento 5
Amsterdam 4
Ardabil 4
Changchun 4
Florence 4
Hefei 4
Mexico City 4
Monmouth Junction 4
Montecorvino Rovella 4
Oslo 4
Phoenix 4
Taizhou 4
Turin 4
Athens 3
Baronissi 3
Cagliari 3
Caxias do Sul 3
Totale 4.127
Salva come PNG Salva come JPEG
Nome #
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 203
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 195
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 160
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 153
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 149
The gut barrier: new acquisitions and therapeutic approaches 139
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 134
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 131
13C-octanoic acid breath test to study gastric emptying time 129
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 129
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 125
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 118
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 112
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 110
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 104
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 103
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 97
The gastrointestinal microbiome - functional interference between stomach and intestine 93
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 92
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 89
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 88
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 88
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 86
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 86
The use of probiotics in different phases of diverticular disease 86
Commensal Clostridia: leading players in the maintenance of gut homeostasis 85
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 84
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 83
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 81
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 77
Bacillus clausii and gut homeostasis: state of the art and future perspectives 76
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 73
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 73
Gut microbiota and inflammatory bowel disease: an update 72
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 71
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 71
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 70
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 67
Development and validation of predictive assessment of complicated diverticulitis score 67
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 66
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 66
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 64
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 64
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 64
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 64
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 60
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 60
Can we predict the efficacy of anti-TNF-α agents? 59
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 59
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 56
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 56
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 55
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 55
Relationship between oral microbiota and periodontal disease: a systematic review 55
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 55
Gut Virome and Inflammatory Bowel Disease 54
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 54
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 54
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 53
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 53
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 53
[Ulcerative colitis] 51
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 51
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 51
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 51
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 50
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 50
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation 49
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 49
Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? 48
Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations 48
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 45
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 45
Role of microbiota and innate immunity in recurrent Clostridium difficile infection 44
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 44
Orphan patients with inflammatory bowel disease - when we treat beyond evidence 44
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 43
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 43
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 42
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 41
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 41
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 41
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 41
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 40
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 39
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 39
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 39
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 38
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 38
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 37
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 36
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape 36
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 35
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 35
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 35
Bariatric procedures and microbiota: patient selection and outcome prediction 34
Radiomics could predict surgery at 10 years in Crohn's disease 33
The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications 32
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 31
Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients 30
Totale 6.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020482 0 0 0 0 46 46 94 41 74 48 96 37
2020/2021667 73 81 14 52 77 54 50 14 59 37 128 28
2021/2022949 93 35 23 66 70 25 12 135 48 94 180 168
2022/20232.198 311 305 164 346 135 248 103 176 239 35 75 61
2023/20241.220 76 313 54 74 42 171 79 49 54 43 123 142
2024/2025563 59 74 206 61 163 0 0 0 0 0 0 0
Totale 7.310